Safety, efficacy, and survival results from a phase 1 study of the oncolytic adenovirus dnx-2401 followed by standard of care radiotherapy for newly diagnosed diffuse intrinsic pontine glioma (DIPG)

Authors
Category Primary study
JournalNeuro-Oncology
Year 2021
This article has no abstract
Epistemonikos ID: 85aab013134d4682c62d58f13850ba72b278680e
First added on: Feb 13, 2025